J. V. Silha and L. J. Murphy, Insulin-like growth factor binding proteins in development, Adv Exp Med Biol, vol.567, pp.55-89, 2005.

W. H. Daughaday, Growth hormone axis overview: somatomedin hypothesis, Pediatr Nephrol, vol.14, pp.537-577, 2000.

O. Isaksson, C. Ohlsson, K. Sjogren, K. Wallenius, and J. O. Jansson, The somatomedin hypothesis revisited in a transgenic model, Growth Horm IGF Res, vol.11, pp.49-52, 2001.

L. Roith, D. Bondy, C. Yakar, S. Liu, J. L. Butler et al., The somatomedin hypothesis: 2001, Endocr Rev, vol.22, pp.53-74, 2001.

F. Lupu, J. D. Terwilliger, K. Lee, G. V. Segre, and A. Efstratiadis, Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth, Dev Biol, vol.229, pp.141-62, 2001.

S. Mohan, C. Richman, and R. Guo, Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms, Endocrinology, vol.144, pp.929-965, 2003.

A. Efstratiadis, Genetics of mouse growth, Int J Dev Biol, vol.42, pp.955-76, 1998.

J. Baker, J. P. Liu, E. J. Robertson, and A. Efstratiadis, Role of insulin-like growth factors in embryonic and postnatal growth, Cell, vol.75, pp.73-82, 1993.

J. P. Liu, J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis, Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r), Cell, vol.75, pp.59-72, 1993.

S. Yakar, E. Canalis, and H. Sun, Serum IGF-1 Determines Skeletal Strength by Regulating Sub-Periosteal Expansion and Trait Interactions, J Bone Miner Res, 2009.

P. F. Backeljauw and L. E. Underwood, Therapy for 6. 5-7. 5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study, J Clin Endocrinol Metab, vol.86, pp.1504-1514, 2001.

S. D. Chernausek, P. F. Backeljauw, J. Frane, J. Kuntze, and L. E. Underwood, Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity, J Clin Endocrinol Metab, vol.92, pp.902-912, 2007.

J. Guevara-aguirre, A. L. Rosenbloom, and O. Vasconez, Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency, J Clin Endocrinol Metab, vol.82, pp.629-662, 1997.

B. Klinger and Z. Laron, Three year IGF-I treatment of children with Laron syndrome, J Pediatr Endocrinol Metab, vol.8, pp.149-58, 1995.

M. B. Ranke, M. O. Savage, and P. G. Chatelain, Insulin-like growth factor I improves height in growth hormone insensitivity: two years' results, Horm Res, vol.44, pp.253-64, 1995.

N. A. Sims, P. Clement-lacroix, D. Ponte, and F. , Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5, J Clin Invest, vol.106, pp.1095-103, 2000.

Y. Wu, H. Sun, S. Yakar, and D. Leroith, Elevated levels of IGF-1 in serum rescue the severe growth retardation of IGF-1 null mice. Endocrinology, 2009.

S. Yakar, M. L. Bouxsein, and E. Canalis, The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone, J Endocrinol, vol.189, pp.289-99, 2006.

S. Yakar, C. J. Rosen, and W. G. Beamer, Circulating levels of IGF-1 directly regulate bone growth and density, J Clin Invest, vol.110, pp.771-81, 2002.

S. Yakar, J. Setser, and H. Zhao, Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice, J Clin Invest, vol.113, pp.96-105, 2004.

K. J. Jepsen, B. Hu, and S. M. Tommasini, Genetic randomization reveals functional relationships among morphologic and tissue-quality traits that contribute to bone strength and fragility, Mamm Genome, vol.18, pp.492-507, 2007.

M. Barron, D. Mcallister, S. M. Smith, and J. Lough, Expression of retinol binding protein and transthyretin during early embryogenesis, Dev Dyn, vol.212, pp.413-435, 1998.

A. Makover, D. R. Soprano, M. L. Wyatt, and D. S. Goodman, An in situ-hybridization study of the localization of retinol-binding protein and transthyretin messenger RNAs during fetal development in the rat, Differentiation, vol.40, pp.17-25, 1989.

D. R. Soprano, K. J. Soprano, M. L. Wyatt, and D. S. Goodman, Induction of the expression of retinol-binding protein and transthyretin in F9 embryonal carcinoma cells differentiated to embryoid bodies, J Biol Chem, vol.263, pp.17897-900, 1988.

M. E. Steinhelper, K. L. Cochrane, and L. J. Field, Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes, Hypertension, vol.16, pp.301-308, 1990.

A. Juul, P. Dalgaard, and W. F. Blum, Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation, J Clin Endocrinol Metab, vol.80, pp.2534-2576, 1995.

J. P. Sabatier, G. Guaydier-souquieres, and D. Laroche, Bone mineral acquisition during adolescence and early adulthood: a study in 574 healthy females. 10-24. years of age, Osteoporos Int, vol.6, pp.141-149, 1996.

D. A. Bailey, H. A. Mckay, R. L. Mirwald, P. R. Crocker, and R. A. Faulkner, A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: the university of Saskatchewan bone mineral accrual study, J Bone Miner Res, vol.14, pp.1672-1681, 1999.

E. Stratikopoulos, M. Szabolcs, I. Dragatsis, A. Klinakis, and A. Efstratiadis, The hormonal action of IGF1 in postnatal mouse growth, Proc Natl Acad Sci, vol.105, pp.19378-83, 2008.

S. M. Tommasini, B. Hu, J. H. Nadeau, and K. J. Jepsen, Phenotypic integration among trabecular and cortical bone traits establishes mechanical functionality of inbred mouse vertebrae, J Bone Miner Res, vol.24, pp.606-626, 2009.

J. Jiang, A. C. Lichtler, and G. A. Gronowicz, Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodeling, Bone, vol.39, pp.494-504, 2006.

M. Zhang, S. Xuan, and M. L. Bouxsein, Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization, J Biol Chem, vol.277, pp.44005-44017, 2002.

G. Zhao, M. C. Monier-faugere, and M. C. Langub, Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation, Endocrinology, vol.141, pp.2674-82, 2000.

P. F. Backeljauw and L. E. Underwood, Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome-a clinical research center study. GHIS Collaborative Group, J Clin Endocrinol Metab, vol.81, pp.3312-3319, 1996.